Novartis, a global leader in Biotechnology and Pharmaceuticals, and leading market intelligence and insights solutions provider Market Logic Software, have officially been nominated for this year’s prestigious ESOMAR Awards in the category “Excellence in AI and Automation in Market Research”.
This nomination recognizes the success of the deployment of Market Logic’s generative AI (gen AI) solution DeepSights to transform knowledge management and accelerate the use of insights at Novartis.
By embedding DeepSights into Sherlock — the company’s internal platform for market insights — Novartis has enabled employees to access curated, trusted data on-demand: ultimately supporting faster, smarter decisions across the organization.
This deployment is not just a technical achievement but also a human one — requiring strong leadership alignment, thoughtful change management, and transparent feedback loops. In adopting this AI-powered approach, Novartis ensured robust adoption across teams, helped establish a scalable and compliant insights engine, and delivered an incredible $30 million in annual research spend reduction.
If you’d like to read more about how Novartis and Market Logic worked together to achieve this, please find the full case study here .
“With the addition of DeepSights generative AI, users are able to get answers faster and more reliably than ever. The solution is a key part of our strategic differentiation and has received positive feedback from across the company.”
— Ian Hook, Director of Business Operations, Novartis
The ESOMAR Awards are a global awards program recognizing “the innovators and visionaries in market research who elevate the industry and set new standards in delivering impactful insights.”
The award winners will be officially announced at the ESOMAR Congress on September 30th in Prague, Czech Republic. More information about these awards can be found on the ESOMAR website.
